Cleared Traditional

DIRECT ANTIBIOTIC INFUSION KIT (K113043) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
68d
Days
Class 2
Risk

K113043 is an FDA 510(k) clearance for the DIRECT ANTIBIOTIC INFUSION KIT. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Summit Medical Products, Inc. (Salt Lake Cty, US). The FDA issued a Cleared decision on December 20, 2011 after a review of 68 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 880.5970 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Summit Medical Products, Inc. devices

Submission Details

510(k) Number K113043 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 13, 2011
Decision Date December 20, 2011
Days to Decision 68 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 115d · This submission: 68d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 106
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K113043.
TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER (PICC) SET
K132885 · Cook Incorporated · Oct 2013
TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER (PICC) SET
K132334 · Cook, Inc. · Aug 2013
THE SHERLOCK 3CG TIP CONFIRMATION SYSTEM (TCS)
K113808 · C.R. Bard, Inc. · Mar 2012
SAPIENS TIP CONFIRMATION SYSTEM
K112744 · C.R. Bard, Inc. · Oct 2011
TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER (PICC)
K111244 · Cook, Inc. · Jun 2011
POWERPICC SV CATHETERS
K102159 · C.R. Bard, Inc. · Nov 2010